NetworkNewsBreaks

MondayNov 29, 2021 12:34 pm

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Inks Agreements with Leading Health and Beauty Company, CBD Beverage Company

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has signed a definitive agreement with Avaria Health & Beauty Corp. Based on the agreement, the two companies will form a joint venture (“JV”), named FloVaria Corp., aimed to facilitate the sale of its award-winning KaLaya brand; sales efforts will be directed in Latin America (“LATAM”). KaLaya has currently sold more than a million units throughout Canada and is carried in major retail locations including Walmart and Loblaws, where the brand has earned the number-two customer loyalty rating in the natural-value, skin-care category. The agreement…

Continue Reading

MondayNov 29, 2021 12:14 pm

NetworkNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces Refiling of Amended, Restated MD&A and Financial Statements

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has amended, restated and refiled information covering the three and six months ended June 30, 2021. Information refiled includes RYAH’s management discussion and analysis (“MD&A”) and condensed, consolidated interim financial statements for the six months ended June 30, 2021. The MD&A material includes information regarding the company's operations, business objectives, and relationships with third parties as well as marketing expenditures incurred during the three- and six-month period ended June 30, 2021. The material…

Continue Reading

MondayNov 29, 2021 11:46 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Notes Adelia Milestone Achievements

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has reported that its wholly controlled subsidiary, Adelia Therapeutics Inc., has achieved key milestones. The milestones were outlined in the agreement between Cybin, Cybin Corp., Cybin US Holdings Inc. and the previous shareholders of Adelia. Based on the agreement, 31,721.5 class B common shares of the company will be issued to Adelia shareholders as a result of relevant milestones being met. Adelia develops medicinal psychedelics designed to provide improved dosing efficacy and therapeutic indices that address unmet medical needs. The company’s primary focus is on the…

Continue Reading

MondayNov 29, 2021 11:27 am

NetworkNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Featured in Latest Market Herald Interview

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, is spotlighted in a recent Power Play interview released by the Market Herald. FuelPositive CEO Ian Clifford talked with Power Play’s Dave Jackson during the interview, down with CEO Ian Clifford to discuss NHHHF’s recent announcement of its operational costing model and timeline for a green ammonia production system. Clifford noted that the company’s initial systems are estimated to produce up to 100 tons of green anhydrous ammonia per year at a cost of C$560 per metric ton. The company plans…

Continue Reading

MondayNov 29, 2021 10:42 am

NetworkNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Releases Report on 2021 Shareholder General and Special Meeting

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, announced that at its annual general and special meeting of shareholders (“AGM”) all agenda items were approved. The meeting was held on Nov. 24, 2021. Included in the agenda items were the election of directors and the appointment of an auditor. According to the company, four individuals were elected to the board, including Marcello Leone, John Campbell, Martino Ciambrelli and Phil Fontaine. In addition, Dale Matheson Carr-Hilton Labonte LLP (“DMCL”) was reappointed as the company auditor for the next year. To view…

Continue Reading

MondayNov 29, 2021 9:30 am

NetworkNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Releases Financial, Operations Report for Latest Period

AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, has reported its unaudited financial results and business highlights for the nine months ended Sept. 30, 2021. Financial highlights include total revenue reaching an estimated  $2.1 million, which is a 55.3% over the same period in 2020, and gross profit margin totaling 59.3%, representing an 8.8% increase from the year before. In addition, the average selling price of ANPC’s CDA-based tests was $71.6,  an increase of 72.3% from 2020. In addition, the company reported cash and cash…

Continue Reading

WednesdayNov 24, 2021 2:38 pm

NetworkNewsBreaks – Why Laredo Oil Inc. (LRDC) Is ‘One to Watch’

Laredo Oil (OTC: LRDC) is an Austin, Texas-headquartered oil and gas exploration and production (“E&P”) company. Its primary focus is on acquiring, developing and operating undervalued conventional oil and gas properties. Having leased 23,739 mineral acres in the Western Williston Basin of Montana, the company expects to drill the first development well at one of the first of 10 potential locations it has identified before year-end. If that well yields the anticipated results, the company plans to begin drilling additional wells there as soon as practical thereafter. Laredo also continues to take other leases in the area. “The company will…

Continue Reading

WednesdayNov 24, 2021 2:23 pm

NetworkNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Makes Expansion of Platinum Vape Brand Top Priority

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently announced the completion of an agreement for the transition of the management at Platinum Vape LLC (“PV”), having settled all additional PV acquisition price considerations. “RWB estimates that production of PV vape carts will increase to over 450,000 in November, a projection that has made expansion of the PV brand a top priority. Michigan and California are proving to be the two vital promising markets pushing for this growth, prompting focus on PV and streamlining its operations,” reads a recent article. The management transition saw the addition of Shea Alderete…

Continue Reading

WednesdayNov 24, 2021 12:37 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates 10-20X Faster Nicotine Delivery in Recent Study

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently conducted a study on canines in collaboration with an independent testing laboratory. The analysis evaluated nicotine benzoate and polacrilex plasma levels in 40 anesthetized male beagle dogs comparing Lexaria’s recently developed, advanced DehydraTECH 2.0 nicotine formulation to concentration-matched controls. The dogs’ blood samples were taken every few minutes over the course of two hours. “The results from the study showed that the generic nicotine benzoate pouch required about 45 minutes to reach its peak delivery rate. In comparison, the DehydraTECH-nicotine benzoate pouch reached peak delivery rates at both eight minutes and again at 30…

Continue Reading

WednesdayNov 24, 2021 12:19 pm

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Looking to Change Narrative in Treating Fibromyalgia, Chronic Pain

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is looking to transform the existing treatment of fibromyalgia, along with other forms of chronic pain, and relieve the suffering of millions of patients. To achieve this, the company is relying on the guidance of its scientific advisory board (“SAB”) as well as research-based work conducted in partnership with the University of Michigan (“U-M”). “According to Tryp’s internal analysis, over 4 million people suffer from fibromyalgia in the United States. Globally, the condition affects an estimated 3-6% of the population (roughly 232-465 million people). Unfortunately, despite the disease afflicting millions, researchers have not yet…

Continue Reading